Leerink downgraded ShockWave Medical (SWAV) to Market Perform from Outperform with a $335 price target after the company entered into an agreement under which Johnson & Johnson (JNJ) will acquire it for $335 per share in cash.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SWAV:
- M&A News: Johnson & Johnson (NYSE:JNJ) Enters Into $13.1B Shockwave Medical Deal
- Shockwave Medical Set for Acquisition by Johnson & Johnson
- ShockWave Medical price target raised to $360 from $290 at Piper Sandler
- Piper says competitive process could materialize for ShockWave
- ShockWave Medical initiated with a Buy at CL King